UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 304

Sortiert nach

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

Blood advances, 2021-12, Vol.5 (24), p.5599-5607

2021

Volltextzugriff (PDF)

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

British journal of haematology, 2016-05, Vol.173 (3), p.444-455

2016

Volltextzugriff (PDF)

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Blood, 2018-06, Vol.131 (26), p.2989-2992

2018

Volltextzugriff (PDF)

Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation

Leukemia, 2022-01, Vol.36 (1), p.257-262

2022

Volltextzugriff (PDF)

Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age

American journal of hematology, 2024-01, Vol.99 (1), p.38-47

2024

Volltextzugriff (PDF)

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

Blood, 2013-03, Vol.121 (13), p.2567-2573

2013

Volltextzugriff (PDF)

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2019-04, Vol.54 (4), p.601-606

2019

Volltextzugriff (PDF)

Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors

Cancer, 2020-05, Vol.126 (10), p.2193-2205

2020

Volltextzugriff (PDF)

Hematopoietic cell transplantation can be safely performed after COVID-19

Bone marrow transplantation (Basingstoke), 2023-12, Vol.58 (12), p.1410-1412

2023

Volltextzugriff (PDF)

Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era

British journal of haematology, 2021-06, Vol.193 (5), p.1004-1008

2021

Volltextzugriff (PDF)

Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant

British journal of haematology, 2023-05, Vol.201 (4), p.e37-e41

2023

Volltextzugriff (PDF)

Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome

Cancer, 2021-05, Vol.127 (10), p.1598-1605

2021

Volltextzugriff (PDF)

Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality

Bone marrow transplantation (Basingstoke), 2021-08, Vol.56 (8), p.2005-2012

2021

Volltextzugriff (PDF)

Correction to: Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation

Leukemia, 2022-01, Vol.36 (1), p.298-298

2022

Volltextzugriff (PDF)

Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission

American journal of hematology, 2023-02, Vol.98 (2), p.E35-E37

2023

Volltextzugriff (PDF)

SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies

Frontiers in immunology, 2022-07, Vol.13, p.904718-904718

2022

Volltextzugriff (PDF)

Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Clinical lymphoma, myeloma and leukemia, 2024-05, Vol.24 (5), p.e196-e204

2024

Volltextzugriff (PDF)

Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning

Cancer, 2017-07, Vol.123 (14), p.2661-2670

2017

Volltextzugriff (PDF)

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

Acta haematologica, 2021-01, Vol.144 (1), p.74-81

2021

Volltextzugriff (PDF)

Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1746-1749

2021

Volltextzugriff (PDF)

Pre-transplant Transfusion Burden and Transplant Outcomes, Is there a Case for Earlier Transplant?

Transplantation and cellular therapy, 2021-08, Vol.27 (8), p.625-626

2021

Volltextzugriff (PDF)

Better allele-level matching improves transplant-related mortality after double cord blood transplantation

Haematologica (Roma), 2015-10, Vol.100 (10), p.1361

2015

Volltextzugriff (PDF)

1 – 25 von 304

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(293)

Publikationsform

Artikel
(303)
Buchkapitel
(1)

Sprache

Englisch
(304)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(96)
Humans
(84)
Hematology
(69)
Female
(61)
Middle Aged
(59)
Male
(58)
Adult
(54)
Aged
(49)
Transplantation
(33)
Hematopoietic Stem Cell Transplantation
(29)
Oncology
(29)
Retrospective Studies
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Treatment Outcome
(28)
Transplantation, Homologous
(25)
Immunology
(24)
Adolescent
(22)
Stem Cell Transplantation
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation

Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors

Hematopoietic cell transplantation can be safely performed after COVID-19

Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era

Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome

Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality

Correction to: Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation

Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission

SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies

CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion

Pre-transplant Transfusion Burden and Transplant Outcomes, Is there a Case for Earlier Transplant?

Better allele-level matching improves transplant-related mortality after double cord blood transplantation

Aktive Filter

Suchergebnisse filtern